Insider · CIK 0001706155
Michael Harsh
Files at NDRA (ENDRA Life Sciences Inc.). First filing -, latest -.
In brief
Michael Harsh files SEC Form 4 as director at NDRA (ENDRA Life Sciences Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael Harsh has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | NDRA ENDRA Life Sciences Inc. | AGrant or award Common Stock | +60,324 | $0.00 | $0 | 65,710 | Jan 23, 2026 |
| Jun 11, 2025 | NDRA ENDRA Life Sciences Inc. | AGrant or award Common Stock | +5,384 | $0.00 | $0 | 5,386 | Jul 1, 2025 |
| Jan 2, 2024 | NDRA ENDRA Life Sciences Inc. | AGrant or award Stock Optionsderivative | +600 | $0.00 | $0 | 600 | Feb 23, 2024 |
Questions about Michael Harsh
Answered from the filings on this page, as of the latest one.
Is Michael Harsh buying or selling?
Michael Harsh has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael Harsh's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Harsh has 0.
Where does Michael Harsh file Form 4?
Michael Harsh has filed Form 4 at NDRA (ENDRA Life Sciences Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.